A double-blind crossover study comparing prophylactic intravenous granisetron alone or in combination with dexamethasone as antiemetic treatment in controlling nausea and vomiting associated with chemotherapy

This publication has 26 references indexed in Scilit:

• Comparison of granisetron alone and granisetron plus dexamethasone in the prophylaxis of cytotoxic-induced emesis
  British Journal of Cancer, 1994
• The antiemetic efficacy and safety of granisetron compared with metoclopramide plus dexamethasone in patients receiving fractionated chemotherapy over 5 days
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1993
• Superiority of Granisetron to Dexamethasone Plus Prochlorperazine in the Prevention of Chemotherapy-Induced Emesis
  JNCI Journal of the National Cancer Institute, 1991
• Effective Control of CMF-Related Emesis with High-Dose Dexamethasone
  American Journal of Clinical Oncology, 1989
• A Double-Blind Trial Comparing Antiemetic Efficacy and Toxicity of Metoclopramide Versus Methylprednisolone Versus Domperidone in Patients Receiving Doxorubicin Chemotherapy Alone or in Combination with Other Antiblastic Agents
  American Journal of Clinical Oncology, 1988
• Methylprednisolone versus Metoclopramide for Prevention of Nausea and Vomiting in Breast Cancer Patients Treated with Intravenous Cyclophosphamide Methotrexate 5-Fluorouracil: A Double-Blind Randomized Study
  Oncology, 1988
• Double-blind controlled trial of the antiemetic efficacy and toxicity of methylprednisolone (MP), metoclopramide (MTC) and domperidone (DMP) in breast cancer patients treated with i.v. CMF
  European Journal of Cancer and Clinical Oncology, 1987
• Methylprednisolone for the Control of CMF-Induced Emesis
  American Journal of Clinical Oncology, 1987
• Antiemetic Efficacy of Dexamethasone
  New England Journal of Medicine, 1984
• On the receiving end—patient perception of the side-effects of cancer chemotherapy
  European Journal of Cancer and Clinical Oncology, 1983